Individual and program predictors of attrition from VA substance use treatment

The Journal of Behavioral Health Services & Research
Geoffrey M CurranBrenda M Booth

Abstract

The study investigated patient- and program-level variables associated with attrition from intensive outpatient (IOP) substance use treatment in a national VA sample. National databases were used to identify a recent cohort of veterans receiving intensive IOP substance use treatment. Attrition was defined as receiving less than five visits of IOP treatment. Patient-level variables examined included age, gender, race, and psychiatric and medical comorbidities. Program-level variables examined included the number of hours of treatment offered, the percentage of patients living on-campus, and extent of staff cuts in the past year. Twenty-seven percent of veterans left treatment early. Being older, female, and having a psychotic disorder was associated with attrition. Program-level factors associated with attrition were the number of hours the program offered treatment, in that more treatment offered was associated with higher attrition. Focus on individual and program level factors associated with attrition is crucial to retaining individuals in treatment.

References

Mar 1, 1991·The International Journal of the Addictions·V AgostiF M Quitkin
Feb 1, 1996·The American Journal of Drug and Alcohol Abuse·V AgostiK Ocepeck-Welikson
Mar 1, 1996·Drug and Alcohol Dependence·A I AltermanA T McLellan
Jan 5, 2000·Drug and Alcohol Dependence·G W JoeK M Broome
Jan 5, 2000·Drug and Alcohol Dependence·K M BroomeG W Joe
May 25, 2001·The American Journal of Drug and Alcohol Abuse·D K KnightD D Simpson
Oct 24, 2001·Journal of Substance Abuse Treatment·G H De Weert-Van OeneG J Schrijvers
Feb 21, 2002·The American Journal of Drug and Alcohol Abuse·Shelly L SayreJohn J Grabowski
Mar 6, 2002·The American Journal on Addictions·Lynne SiquelandMadeline Gladis
Mar 12, 2002·Issues in Mental Health Nursing·P J KellyE Mason
May 11, 2002·Journal of Psychoactive Drugs·Ronald E Claus, Lisa R Kindleberger
May 11, 2002·Journal of Psychoactive Drugs·Cynthia L ArfkenCharles R Schuster
May 30, 2002·The Journal of Behavioral Health Services & Research·Geoffrey M CurranBrenda M Booth
Dec 24, 2002·Journal of Substance Abuse Treatment·Deborah L HallerKathryn S Dawson
Jan 4, 2003·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Joseph M. WhiteWayne Young
Oct 15, 2003·Psychiatric Services : a Journal of the American Psychiatric Association·Geoffrey M CurranBrenda M Booth
Nov 25, 2003·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Susan M O'ConnorRobert van Eijk
Apr 6, 2004·Journal of Substance Abuse Treatment·Andrea C King, Stephanie A Canada
Jun 21, 2005·Addictive Behaviors·Samuel A BallBruce J Rounsaville
Apr 11, 2006·Substance Use & Misuse·Alicia N JustusKenneth R Weingardt

❮ Previous
Next ❯

Citations

Oct 11, 2008·The Journal of Behavioral Health Services & Research·Brenda M BoothRedonna K Chandler
Sep 13, 2014·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Jennifer J RunnalsUNKNOWN Veterans Integrated Service Network (VISN) 6 Mental Illness Research Education and Clinical Centers' (MIRECC) Women Veterans
Jan 12, 2016·Journal of Substance Use·J CattieUNKNOWN TMARC Group
Feb 13, 2013·The American Journal on Addictions·R Kathryn McHughMichael W Otto
Sep 14, 2013·Clinical Psychology Review·Hanne H BrorsonFanny Duckert
Sep 19, 2017·The American Journal on Addictions·James MckowenTimothy Wilens
Sep 27, 2014·Substance Abuse Treatment, Prevention, and Policy·David Loveland, Hilary Driscoll
May 15, 2010·The American Journal of Drug and Alcohol Abuse·Michael MancinoBrenda M Booth
Jan 19, 2016·The Journal of Behavioral Health Services & Research·Kaitlin LilienthalGregory P Beehler
Oct 1, 2017·Nordisk alkohol- & narkotikatidskrift : NAT·Helle Wessel AnderssonRolf W Gråwe
Apr 22, 2021·Substance Use & Misuse·Fivos E PapamalisKevin Knight

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.